Edition:
United States

News: Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

4.33USD
27 May 2016
Change (% chg)

$0.16 (+3.84%)
Prev Close
$4.17
Open
$4.17
Day's High
$4.34
Day's Low
$4.10
Volume
417,243
Avg. Vol
--
52-wk High
--
52-wk Low
--

Select another date:

Thu, May 5 2016

BRIEF-Celldex reports Q1 loss per share $0.35

* Q1 earnings per share view $-0.35 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Celldex discontinues late-stage study of brain cancer vaccine

Celldex Therapeutics Inc said it would discontinue a late-stage study of its brain cancer vaccine after an independent interim analysis suggested the therapy might not show a statistically significant benefit in patient survival compared with standard chemotherapy.

UPDATE 2-Celldex discontinues late-stage study of brain cancer vaccine

* Stock drops 54 pct premarket (Adds analyst comment, details from conference call)

Celldex discontinues late-stage study of brain cancer vaccine

March 7 Celldex Therapeutics Inc said it would discontinue a late-stage study of its brain cancer vaccine after an independent interim analysis suggested the therapy might not show a statistically significant difference in survival rates compared with chemotherapy.

Select another date: